Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.7B | 11.1B | 10.4B | 10.6B |
Cost of revenue | 9.2B | 8.2B | 7.4B | 7.9B |
Gross profit | 3.6B | 2.9B | 3.0B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 178M | 171M | 80M | 111M |
Other operating expenses | 91M | 98M | 97M | 97M |
Operating income | 3.3B | 2.6B | 2.8B | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 258M | 223M | 154M | 158M |
Other income expense | 67M | -862M | 139M | -146M |
Pretax income | 3.1B | 1.6B | 2.8B | 2.3B |
Tax provision | 639M | 448M | 543M | 541M |
Net income | 2.5B | 1.1B | 2.3B | 1.7B |
Basic EPS | 1.2 | 0.5 | 1.1 | 0.8 |
Diluted EPS | 1.2 | 0.5 | 1.1 | 0.8 |
Basic average shares | 2.1B | 2.1B | 2.1B | 2.1B |
Diluted average shares | 2.1B | 2.1B | 2.1B | 2.1B |
EBITDA | 5.2B | 4.6B | 4.4B | 4.2B |
Net income from continuing op. | 2.5B | 1.1B | 2.3B | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |